Cargando…
Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720249/ https://www.ncbi.nlm.nih.gov/pubmed/36478983 http://dx.doi.org/10.1016/j.jdcr.2022.10.035 |
_version_ | 1784843514136231936 |
---|---|
author | Moore, Angela Y. Hurley, Kara |
author_facet | Moore, Angela Y. Hurley, Kara |
author_sort | Moore, Angela Y. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9720249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-97202492022-12-06 Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris Moore, Angela Y. Hurley, Kara JAAD Case Rep Case Report Elsevier 2022-11-05 /pmc/articles/PMC9720249/ /pubmed/36478983 http://dx.doi.org/10.1016/j.jdcr.2022.10.035 Text en © 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access.. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Moore, Angela Y. Hurley, Kara Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris |
title | Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris |
title_full | Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris |
title_fullStr | Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris |
title_full_unstemmed | Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris |
title_short | Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris |
title_sort | dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720249/ https://www.ncbi.nlm.nih.gov/pubmed/36478983 http://dx.doi.org/10.1016/j.jdcr.2022.10.035 |
work_keys_str_mv | AT mooreangelay dupilumabmonotherapysuppressesrecalcitrantpemphigusvulgaris AT hurleykara dupilumabmonotherapysuppressesrecalcitrantpemphigusvulgaris |